Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

The majority of Enbrel's sales are in rheumatology, as the drug is approved in indications including rheumatoid arthritis, plaque psoriasis ... launch its biosimilar Remicade until October ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

If you have psoriasis, you may feel like this autoimmune disease is plenty to cope with all on its own. But unfortunately there are a number of other health issues linked to the condition.

Psoriasis attacks healthy cells, causing inflammation that leads to plaques and other skin changes. Some of the same underlying triggers that drive psoriasis may also pose problems for your heart ...

Celltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe in the coming months in rheumatoid arthritis, after a ...

These ingredients are ideal for inflammatory skin conditions like eczema and psoriasis because they can help relieve itchiness, dryness and scaling on the skin. To strengthen your skin barrier ...